Search For

Impact of metabolic reprogramming on the immune response in hepatocellular carcinoma

Yttrium-90 combination therapies in hepatocellular carcinoma: current evidence and future directions

Patient-derived tumor organoid models for functional precision oncology in hepatocellular carcinoma

Conversion and neoadjuvant systemic therapy for intrahepatic cholangiocarcinoma: from technical resectability to biology-driven surgical selection - a systematic review and meta-analysis

Resistance to immune checkpoint inhibitors in hepatocellular carcinoma: mechanisms and combination strategies to overcome it

Histone lactylation in hepatocellular carcinoma: a key epigenetic hub linking metabolic reprogramming and the immune microenvironment

Multi-task neural network enhanced by data augmentation and ROI optimization for prognosis and MVI prediction in HCC using contrast-enhanced CT

Review of advances in FOLFOX-HAIC for conversion, neoadjuvant, and adjuvant therapy in hepatocellular carcinoma

Cordycepin alleviates oxaliplatin-induced fatty liver disease

Kupffer cells and monocyte-derived macrophages in the pathogenesis and treatment of hepatocellular carcinoma

Reconstructing strategies for precision diagnosis and treatment of liver cancer based on multi-modal data

The role of “treatment unfeasibility” in the multiparametric, multidisciplinary, and expert evaluation of HCC patients